Caricamento...
Late Pulmonary Embolism after COVID-19 Pneumonia despite Adequate Rivaroxaban Treatment
INTRODUCTION: SARS-CoV-2 infection may predispose patients to thrombotic disease. Patients with COVID-19 pneumonia who are receiving non-vitamin K antagonists or direct oral anticoagulants for chronic disease are usually switched to heparin treatment during hospitalization. However, information abou...
Salvato in:
| Pubblicato in: | Eur J Case Rep Intern Med |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SMC Media Srl
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7350955/ https://ncbi.nlm.nih.gov/pubmed/32665940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12890/2020_001790 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|